User talk:ImperfectlyInformed

Note to self on commitments and subscriptions
My current focus (as of 2018-03) is software development, career and personal development. Until I figure out how to sustainably contribute, unsubscribing from:
 * the tech news weekly - at some point, determine whether a more active role is in scope and sign up as an ambassador at https://meta.wikimedia.org/wiki/Tech/Ambassadors/List
 * the Feedback_request_service Requests for Comment at 1 per month of:
 * categories of economy, trade, and companies
 * Math, science, and technology
 * Politics, government, and law

II | (t - c) 17:21, 17 March 2018 (UTC)

Okay, I'm back
I had other priorities. And then I realized that I care too much about this project.

But first, I needed to make a point. When you go so far as to defend editors who clearly do not understand the subject matter of the article -- and obviously have made no effort to engage with the material -- and then threaten to take other editors to arbitration for calling out an obvious argument from ignorance, that comes across as not only uncivil but obnoxious and threatening on your part. At this rate, you will be the only person covering the law articles on this encyclopedia.

With the benefit of hindsight, I'll readily admit that I should have attempted to first coolly attempt to elicit any reasoned rationale for the proposed move from User:Arrivisto before drawing conclusions. (As you should have noticed by now, that user's next statement confirmed the obvious: he does not understand what is a contract.) But that logic goes both ways. There were more tactful ways to call me out for jumping to conclusions (as User:BD2412 did), short of making a threat.

In the meantime, I've noticed over a dozen examples of vandalism or just grossly incompetent editing on important articles that slipped through during the past seven months, including Law of the United States (where the vandalism was quite subtle) and Product liability (which was formerly a decent summary and is now utterly incoherent). I deliberately refrained from reverting those edits in order to confirm a longstanding theory of mine: I'm the only editor who cares enough to monitor those articles regularly enough to recognize bad edits. I hope you're prepared to step up if I ever decide that I no longer care. --Coolcaesar (talk) 08:11, 26 November 2018 (UTC)
 * I'm very glad that you're back! I'll refrain from repeating myself, and I appreciate your cool tone. I don't want to sound condescending, but I think you will find that the restraint of a cool and professional tone is well worth the effort. One of my favorite quotes is from Schopenhauer on the topic:

"It is a wise thing to be polite; consequently, it is a stupid thing to be rude. To make enemies by unnecessary and willful incivility, is just as insane a proceeding as to set your house on fire. For politeness is like a counter--an avowedly false coin, with which it is foolish to be stingy."
 * I also must stress WP:GOODFAITH, and hope you look at ignorance as an opportunity for education. I think we should consider doing conference calls when things get heated. II  | (t - c) 08:31, 26 November 2018 (UTC)

Page for Richard T. Burke?
Hi, ImperfectlyInformed. I see you recently did some solid editing to the page about UnitedHealth Group. I'd like to briefly propose the idea of creating a page for Richard T. Burke, the founder and chairman of UnitedHealth group. The founder and chairman of the world's largest healthcare company deserves a page. Based on your recent edits to the UnitedHealth Group page, I'm confident you would do a good job of getting it started, much better than I would. If you have no interest, and don't want this on your talk page, don't hesitate to delete this comment. Just an idea. Anyway, thanks for the edits to UnitedHealth Group. Carlsonaar (talk) 10:54, 8 December 2018 (UTC)


 * I agree that he could use a page, but why don't you think you could do a good job? Let's work on it together. Can you do some searching for sources and start a stub in your draft space?  II  | (t - c) 14:51, 8 December 2018 (UTC)


 * Thanks for the sources you left on the talk page for UnitedHealth Group. I've never started a page before, but there's a first time for everything. I have no excuse not to just do it myself. I'll see if I can give it a go. Thanks again for the sources and the encouragement. Carlsonaar (talk) 10:34, 11 December 2018 (UTC)

Rikkunshito edit
Hello -- I reverted this edit because a) the studies reviewed were on small numbers of subjects or done using animals in lab studies (a very low-quality review), and b) that journal published low-quality, non-MEDRS content, with a low (2.0) impact factor. Best to avoid citing literature from EBCAM for WP medical content. Kind regards --Zefr (talk) 02:57, 20 April 2019 (UTC)
 * , there is no such thing as a "MEDRS" journal, as noted at the last paragraph at Identifying_reliable_sources_(medicine) (i.e., there is no black/white list). I understand that we have a certain United States institutional bias, but I have no idea what journals are on your list, and I'm probably not OK with whatever small list (mostly by not freely-accessible) publishers you have in mind. Seems to be a fairly arbitrary decision - all review articles discuss a quite varied level of evidence, and requiring that all medical content discuss - what, multicenter RCTs? - seems quite unrealistic. Where would you prefer to handle this dispute resolution? We can go to WP:3O, then WP:RFC, and so on. As I'm sure you are aware, impact factor is controversial - see Impact_factor. I like a PageRank-based algorithm, altho that's a topic for another time. II  | (t - c) 04:20, 20 April 2019 (UTC)
 * Note, I think that this institutional bias is something that needs to be discussed on a broader meta-level. There's arguably a cultural bias bordering on unethical (I'll try to avoid more inflammatory language) in how Wikipedia treats publication by researchers from anywhere other than the United States (or maybe Europe). In this case, there's lots and lots of literature including reviews - if you don't like that journal, we can use another one. But if *all* 14 reviews, plus the ones since 2014 (somewhere around a half-dozen), then that's frankly troubling. My understanding is that rikkunshito is also approved by the government of Japan for cachexia treatment; I haven't done a full literature in a few years. II  | (t - c) 04:45, 20 April 2019 (UTC)
 * "there is no black/white list". Actually, WP does maintain a source blacklist called "Crapwatch" here, and EBCAM is on it (under Alternative medicine, which disqualifies that journal from use on medical topics). We can find a better ref, perhaps this. For the Appetite article, I'm ok with saying that rikkunshito is "under preliminary research to identify its potential use as an appetite stimulant". This is fact, but to state it more conclusively is misleading. I'm copying part of this discussion to the Appetite talk page. If you're curious about the opinion of other medical editors, I suggest an entry on WT:MED. --Zefr (talk) 17:28, 20 April 2019 (UTC)
 * , actually being about alt med alone isn't disqualifying on its own. E.g. Focus on Alternative and Complementary Therapies is very likely fine, for example. The issue with EBCAM is that it, like many but not all journals on alternative medicine, is that its peer-review process is a joke, and will publish pretty much anything 'pro' alt med, regardless of the scientific merits. &#32; Headbomb {t · c · p · b} 21:05, 20 April 2019 (UTC)
 * Ultimately it's fair to say that we are the final arbiter of what we allow in and we should maintain high-quality, but the more that we can base determinations on actual evidence, the better. It's a bit hypocritical to accuse journals of being fraudulent if we can't readily point to good evidence. I don't follow scholarly publishing like I used to (altho apparently I'm still #3 in authorship of academic publishing) but Jeffrey Beall stopped updating his list a couple years ago. And EBCAM, for example, was not on the list, and Hindawi was taken off it in 2010. It seems that the anonymous person who revived the list who will not be updating it. Hopefully we'll have more work to rely upon - things like Retraction Watch, more "stings", maybe Cabell's, or even standardized processes around review could help. Blithely saying that an entire journal is unusable because some American librarian said years ago so isn't really very rigorous.
 * As far as the alternative medicine field, EBCAM is notable in that it has been called out specifically by Ernst. But I'm not sure how the algorithm in general handles better-run AM journals. Seems like it might pick up "unreliable fields" without looking at the substance of such publications. Certainly if an alternative medicine publication uncritically publishes stuff like homeopathy or whatever, it shouldn't be used. But not sure such analysis has been done in most cases.
 * Also, as mentioned in the talk, ultimately these efforts should merge with WikiCite which aims to make automatic quality-checking easier. Exciting stuff! II  | (t - c) 07:37, 21 April 2019 (UTC)
 * EBCAM has a lot more going against it than just Beall's word. See, e.g. the thoughts of one of its founding editors, who describes its articles as 80% of 'useless rubbish' with a peer-review system that is 'farcical'. &#32; Headbomb {t · c · p · b} 07:45, 21 April 2019 (UTC)
 * Which shouldn't be much of a surprise, given the pay-to-publish model it has. &#32; Headbomb {t · c · p · b} 07:57, 21 April 2019 (UTC)

In choosing high-quality sources for WP medical content, editors also have to maintain a healthy skepticism and assess candidate sources critically. The original object of this discussion - rikkunshito use to improve appetite reported in the EBCAM review ("Mogami") - was a systematic review, which (by title) qualifies it for consideration, rather than dismissing it outright because it's a CAM source. Inspecting the clinical studies in the Mogami review, however, reveals they were all disqualifying studies with low subject numbers and weak designs (section 3.1), i.e., if judged individually, each would be called "primary research" at best and not used. So, is a review of questionable primary studies acceptable because it consolidates clinical studies on the rikkunshito-appetite topic? Some would say 'yes', although I maintain it's 'no'; that the editorial review allowed Mogami to be published testifies about the low-overall quality of the journal. The Ernst editorial makes an additional case against EBCAM and by inference other CAM journals: the research quality is generally so poor that authors seek to pay their way into publication. Another way of looking at this is to ask if the Mogami 'systematic review' could pass muster in a rigorously reviewed journal, like Lancet or NEJM. Definitely not, leading us to find a more reliable source for a topic that will always be nebulous for defining efficacy, specificity, and safety, as was done for rikkunshito and ghrelin, although not with much satisfaction (for me). --Zefr (talk) 14:11, 21 April 2019 (UTC)
 * For II's skepticism concerning WP editors and choices for source quality, background here. --Zefr (talk) 15:24, 21 April 2019 (UTC)
 * (edit conflict) We need to move away from journal-level medals. There is no need to launch an investigation into the journal nor to read tea leaves about its average quality: just look straight into the reality at hand, i.e. the authors of this work. I say they're clearly suspicious, given 1) their academic credentials and experience seem unknown, 2) they are working for a private company. When you see that their employer sells that product and that they declare a conflict of interest for this reason, there's no need to look further. Their work cannot alone be used for any such claim, much like any publication by Monsanto swearing that glyphosate is safe, whatever journal contains it. The article could however be used as a source for a sentence like "companies selling rikkunshito have attempted to demonstrate its benefits for X compared to Y", or something similar. Nemo 15:27, 21 April 2019 (UTC)
 * Zefr, NEJM is not an example of a "rigorously reviewed journal": in fact it tops the retraction index by a large margin and its articles on average have questionable statistical qualities. Nemo 16:22, 21 April 2019 (UTC)
 * . Good points about the Mogami study. The article you provide on high impact journals does state "the best reporting practices ... were present in more than 80% of articles published in NEJM and Lancet". There will be arguments all around about what are the most respected journals and why, but NEJM has been ranked highest by almost every index for years or as long as there have been impact factors. Most medical authors would also attest that getting an article published in NEJM may be the most difficult of all journals. --Zefr (talk) 16:42, 21 April 2019 (UTC)
 * Tressoldi et al. appear to consider those best practices essential, to the point that any score below 100 % should be considered a failure. I cannot say whether they are right, but the point is that journal-level metrics like the impact factor are very poor predictors of the quality of individual publications. I understand that a lot of the best researchers will flock to such famous journals, but fraudsters will too, for the same reasons.
 * When you see OUP and Wiley publish articles on glyphosate co-authored by Monsanto employees without even a standard COI acknowledgement, you can't help but conclude that their pre-publication checks are astonishingly inadequate: as for minimal quality checks which the publisher ought to guarantee, Hindawi did a better job with the Tsumura article than OUP and Wiley did in that case. Should we just trash anything anyone publishes with them? Certainly not. We need to take a critical look at every source equally.
 * Please just forget using the impact factor or any journal-related metric ever again in a Wikipedia discussion and I guarantee you'll be better off! Nemo 10:57, 26 April 2019 (UTC)
 * , thought of this conversation when I saw We Tried to Publish a Replication of a Science Paper in Science. The Journal Refused. - in my admittedly limited experience (I stopped reading regularly reading Science and Nature years ago) it seems clear that the high-profile journals prioritize splashiness over rigor; this was also part of the explanation for why a 2011 study found that "journal retraction index versus the impact factor revealed a surprisingly robust correlation between the journal retraction index and its impact factor (P < 0.0001 by Spearman rank correlation)" . What gets measured gets managed, and prolly part of the reason that *Science* refuses to publish a failed replication is that it doesn't see it see it as interesting enough to increase the impact factor. Additionally, "Perversely, a weak paper that is being refuted will augment the impact factor, as will a retracted article, because although the article may have been retracted, the citations of this article will still count" . Hopefully we will have an open-source alternative eventually which can be fine-tuned. Generalist journals don't really seem that great to me, but I suppose it's fair to rebut that at least high IF journals (1) represent areas where high-profile discussion is happening and (2) have lots of submissions and therefore take their pick of the litter. II  | (t - c) 07:10, 24 June 2019 (UTC)

Huh?
What on earth is promotional about MY edit? Nothing. Revert your revert of my edit, or justify it. (Leave your revert of the promotional edits, by all means.) Re https://en.wikipedia.org/w/index.php?title=Medical_laboratory&curid=12941686&diff=898189564&oldid=898184087 2601:643:8680:158F:5972:9BD:41CB:349 (talk) 01:11, 22 May 2019 (UTC)
 * , hmm, sorry, that was an accident. But linking LDT there is overlinking - it's the first thing linked in that sentence. II  | (t - c) 01:24, 22 May 2019 (UTC)

Potassium bicarbonate
I replied to your comment on Potassium bicarbonate, but now it does not exist. Has it been deleted? _ _ _ _ 83d40m (talk) 13:16, 26 May 2019 (UTC)

You are cordially invited to the SPIE Photonics West edit-a-thon on 02.02.2020
Join us for the SPIE Photonics West edit-a-thon this Sunday, 02.02.2020!




 * I am delighted to invite you to the SPIE Photonics West 2020 edit-a-thon, at Park Central Hotel (Franciscan I, 3rd Level / 50 Third Street / San Francisco, California), on Sunday, February 2, 2020, at 5:00-7:00pm.


 * Newcomers and experienced Wikimedians are welcome to participate alongside SPIE conference attendees. Admission is free. Training will be provided.


 * Details and sign-in here

See you soon! All the best, --Rosiestep (talk) 06:59, 31 January 2020 (UTC) via MassMessaging

Investment_fund
Thanks for identifying the source of the material in your edit.

This type of edit does get picked up by Copy Patrol and a good edit summary helps to make sure we don't accidentally revert it. However, for future use, would you note the best practices wording as outlined at Copying_within_Wikipedia? In particular, adding the phrase "see that page's history for attribution" helps ensure that proper attribution is preserved. S Philbrick (Talk)  13:45, 28 February 2020 (UTC)

Ah, ok. I'll take a look and do that next time. II | (t - c) 15:37, 28 February 2020 (UTC)

Thank you for being one of Wikipedia's top medical contributors!

 * please help translate this message into your local language via meta

Thanks again :-) --  Doc James  along with the rest of the team at Wiki Project Med Foundation 18:35, 5 March 2020 (UTC)

Nomination of BlueFocus Communication Group for deletion
A discussion is taking place as to whether the article BlueFocus Communication Group is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/BlueFocus Communication Group until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Hatchens (talk) 06:50, 17 August 2020 (UTC)
 * dude, I've been editing Wikipedia since 2007, especially focused on large, notable businesses. You have been editing since 2020. I have never written to promote or advertise anything. Please remove your baseless personal attacks (see WP:NPA, "Accusations about personal behavior that lack evidence. Serious accusations require serious evidence, usually in the form of diffs and links", Casting_aspersions). If you do not cease making baseless personal attacks, I will report you to the administrators noticeboard. II  | (t - c) 11:11, 18 August 2020 (UTC)
 * Dear, personal attack?? I apologize for the inconvenience. Ok, please report at WP:ANI. I'll meet you there. -Hatchens (talk) 12:27, 18 August 2020 (UTC)
 * Per Skip the drama at the top of the page, I'm tagging some recently active admins for advice:, , , is it just normal now to accuse people of being paid spammers w/o evidence? What is my recourse here? II  | (t - c) 12:31, 18 August 2020 (UTC)
 * I see the ping, but this isn't the sort of thing I generally deal with. I have said I have differences with WP's COI policies and so I don't get involved with them. I don't by saying that mean to imply anything about anyone.--Wehwalt (talk) 12:59, 18 August 2020 (UTC)
 * , do you deny that you are directly accusing me of being a paid editor? Do you have any evidence of that? How do you reconcile that with the No personal attacks policy quoted above? To be clear, perhaps you don't understand when you did that. I'm the creator of the above mentioned article, and you slapped the template on it saying that it was probably created for money, and opened the AfD by saying that "This page is made for PR/Advertising WP:PROMO purpose", basically saying you can read my mind. I wrote the article because this is a Chinese advertising company infiltrating the worldwide advertising space, which is a major public concern. Don't assume other people's motivations w/o evidence. See also our discussion at Template_talk:Undisclosed_paid and WP:GOODFAITH. II  | (t - c) 12:49, 18 August 2020 (UTC)
 * , I see that you created GO_Navigator. I certainly don't believe this is notable (a supply ship? seriously? zero significant coverage, just passing mention), but how do I know you aren't a paid promoter? I don't. So why don't I slap the paid editing tag on it, nom for AfD, and accuse you of being paid to write it to promote SpaceX or Guice Offshore? Because that would assume bad faith and create a hostile environment. Does that allow you to understand a little better why we have these policies? II  | (t - c) 13:05, 18 August 2020 (UTC)
 * Dear, the necessary proof has been added to my nomination for your kind perusal;
 * 1. Its' media citations are completely sponsored ones and part of either press release sites (1, 2, 3, 4, 5) or something near about like that. In short, it doesn't have much citations from sites listed on WP:RS or WP:RSPMISSING.
 * 2. Just 4 passing mentions in Books.
 * 3. Just a couple passing mentions in Academic articles.
 * 4. Nothing on JSTOR.
 * 5. Nothing on NYT.
 * I apologize for not providing these proofs in the first place and creating this ruckus. - Hatchens (talk) 16:46, 18 August 2020 (UTC)
 * Dear, after going through the reasons mentioned in this AfD discussion and also as per the points raised in WP:ANI, I had withdrawn my AfD nomination for BlueFocus Communication Group and requested concerned authority for a quick closure. Also, I would like to apologize to you for unknowingly indulging in "personal attack" which has created an inconvenient situation for everyone in our community. In the end, thank you for guiding me and make me more aware of the rules which we all need to adhere, with absolute integrity. - Hatchens (talk) 06:32, 19 August 2020 (UTC)
 * 4. Nothing on JSTOR.
 * 5. Nothing on NYT.
 * I apologize for not providing these proofs in the first place and creating this ruckus. - Hatchens (talk) 16:46, 18 August 2020 (UTC)
 * Dear, after going through the reasons mentioned in this AfD discussion and also as per the points raised in WP:ANI, I had withdrawn my AfD nomination for BlueFocus Communication Group and requested concerned authority for a quick closure. Also, I would like to apologize to you for unknowingly indulging in "personal attack" which has created an inconvenient situation for everyone in our community. In the end, thank you for guiding me and make me more aware of the rules which we all need to adhere, with absolute integrity. - Hatchens (talk) 06:32, 19 August 2020 (UTC)
 * I apologize for not providing these proofs in the first place and creating this ruckus. - Hatchens (talk) 16:46, 18 August 2020 (UTC)
 * Dear, after going through the reasons mentioned in this AfD discussion and also as per the points raised in WP:ANI, I had withdrawn my AfD nomination for BlueFocus Communication Group and requested concerned authority for a quick closure. Also, I would like to apologize to you for unknowingly indulging in "personal attack" which has created an inconvenient situation for everyone in our community. In the end, thank you for guiding me and make me more aware of the rules which we all need to adhere, with absolute integrity. - Hatchens (talk) 06:32, 19 August 2020 (UTC)

, Wrt : Happy to provide advice, but I'm afraid my interest in that page was transient and I don't see much need to build it up - I was filling the gap, as I don't like to see highly notable corporations missing from Wikipedia. The article may be built up as news flows in. However, you could do me a favor and fix the talk page WikiProject templates for it? I'm a big fan of WP:SUMMARY and in many cases a smaller article is better. There's no point in repeating all the information on Wikipedia - if people want tons of detail, there's citations. I might be inclined to work on advertising agency, altho my understanding of the industry is limited. But sure, let's look at collaborating. One other area you could help me out is filling more gaps in areas where Wikipedia is missing a large corporation. In my opinion, most corporations with market caps over $1b USD deserve articles, and we're missing quite a lot of them. Whether you want to go the extra mile and create WP:DYK is up to you; I don't do that because my focus when I do (rarely) create articles is on filling gaps, not publishing a fancy article or getting some credit. II | (t - c) 07:27, 19 August 2020 (UTC)

Nomination of Industrial Hygiene Foundation for deletion
A discussion is taking place as to whether the article Industrial Hygiene Foundation is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Industrial Hygiene Foundation until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Cupper52 (talk) 18:34, 11 January 2021 (UTC)

Invitation to take part in a survey about medical topics on Wikipedia
Dear fellow editor,

I am Piotr Konieczny, a sociologist of new media at Hanyang University (and User:Piotrus on Wikipedia). I would like to better understand Wikipedia's volunteers who edit medical topics, many associated with the WikiProject Medicine, and known to create some of the highest quality content on Wikipedia. I hope that the lessons I can learn from you that I will present to the academic audience will benefit both the WikiProject Medicine (improving your understanding of yourself and helping to promote it and attract new volunteers) and the wider world of medical volunteering and academia. Open access copy of the resulting research will be made available at WikiProject's Medicine upon the completion of the project.

All questions are optional. The survey is divided into 4 parts: 1 - Brief description of yourself; 2 - Questions about your volunteering; 3 - Questions about WikiProject Medicine and 4 - Questions about Wikipedia's coverage of medical topics.

Please note that by filling out this questionnaire, you consent to participate in this research. The survey is anonymous and all personal details relevant to your experience will be kept private and will not be transferred to any third party.

I appreciate your support of this research and thank you in advance for taking the time to participate and share your experiences! If you have any questions at all, please feel free to contact me at my Wikipedia user page or through my email listed on the survey page (or by Wikipedia email this user function).

The survey is accessible through the LINK HERE.

Piotr Konieczny Associate Professor Hanyang University If you wish to opt-out of future mailings, please remove yourself from the mailing list. MediaWiki message delivery (talk) 22:24, 13 December 2021 (UTC)

Invitation to Local Wikimania Event in San Francisco this Friday
Hi!

Wikimania is happening and hopefully you're enjoying the sessions. While it's fairly last minute, you're warmly invited to participate in the local Wikimania-themed meetup in the Wikimedia Foundation office this Friday (tomorrow!). You will have to register in advance, but we would love to see more people from the WikiSalon community participate! For more information and registration, please check out Wikimania 2022/San Francisco Meetup.

The event will involve hacking, teaching, learning, and celebrating and we'll have snacks. We will have the opportunity to watch live sessions at Wikimania together in the afternoon. The rest of the day we'll have opportunity to participate in the hackathon, and we may have some on-demand workshops/learning sessions.

In case we run out of space, it's first-come-first-serve so let us know soon! Hope to see you there.

(Subscribe/Unsubscribe to this talk page notice here)

On behalf of the Bay Area Wiki Salon team and Bittakea, Effeietsanders

ArbCom 2022 Elections voter message
 Hello! Voting in the 2022 Arbitration Committee elections is now open until 23:59 (UTC) on. All eligible users are allowed to vote. Users with alternate accounts may only vote once.

The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.

If you wish to participate in the 2022 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add to your user talk page. MediaWiki message delivery (talk) 00:42, 29 November 2022 (UTC)

Speedy deletion nomination of AAIS


A tag has been placed on AAIS requesting that it be speedily deleted from Wikipedia. This has been done under section G14 of the criteria for speedy deletion, because it is a disambiguation page which either
 * disambiguates only one extant Wikipedia page and whose title ends in "(disambiguation)" (i.e., there is a primary topic);
 * disambiguates zero extant Wikipedia pages, regardless of its title; or
 * is an orphaned redirect with a title ending in "(disambiguation)" that does not target a disambiguation page or page that has a disambiguation-like function.

Under the criteria for speedy deletion, such pages may be deleted at any time. Please see the disambiguation page guidelines for more information.

If you think this page should not be deleted for this reason, you may contest the nomination by visiting the page and clicking the button labelled "Contest this speedy deletion". This will give you the opportunity to explain why you believe the page should not be deleted. However, be aware that once a page is tagged for speedy deletion, it may be deleted without delay. Please do not remove the speedy deletion tag from the page yourself, but do not hesitate to add information in line with Wikipedia's policies and guidelines. If the page is deleted, and you wish to retrieve the deleted material for future reference or improvement, then please contact the. Shhhnotsoloud (talk) 16:03, 18 March 2023 (UTC)

ArbCom 2023 Elections voter message
 Hello! Voting in the 2023 Arbitration Committee elections is now open until 23:59 (UTC) on. All eligible users are allowed to vote. Users with alternate accounts may only vote once.

The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.

If you wish to participate in the 2023 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add to your user talk page. MediaWiki message delivery (talk) 00:28, 28 November 2023 (UTC)